No abstract available
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Acrylamides / pharmacology*
-
Agammaglobulinaemia Tyrosine Kinase
-
Antineoplastic Agents / pharmacology*
-
Drug Resistance, Neoplasm
-
Drug Synergism
-
Enzyme Activation / drug effects
-
Humans
-
Lenalidomide
-
Lymphoma, Mantle-Cell / drug therapy
-
Lymphoma, Mantle-Cell / genetics*
-
Lymphoma, Mantle-Cell / metabolism*
-
Mutation*
-
NF-kappa B / antagonists & inhibitors
-
NF-kappa B / genetics*
-
Protein Kinase Inhibitors / pharmacology
-
Protein-Tyrosine Kinases / antagonists & inhibitors
-
Pyrimidines / pharmacology*
-
Thalidomide / analogs & derivatives*
-
Thalidomide / pharmacology
Substances
-
Acrylamides
-
Antineoplastic Agents
-
NF-kappa B
-
Protein Kinase Inhibitors
-
Pyrimidines
-
Thalidomide
-
spebrutinib
-
Protein-Tyrosine Kinases
-
Agammaglobulinaemia Tyrosine Kinase
-
Lenalidomide